Market Cap 1.83B
Revenue (ttm) 1.26B
Net Income (ttm) 363.05M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 28.85%
Debt to Equity Ratio 0.00
Volume 288,000
Avg Vol 166,174
Day's Range N/A - N/A
Shares Out 65.90M
Stochastic %K 32%
Beta 0.25
Analysts Hold
Price Target $30.17

Company Profile

Galapagos NV, a biotechnology company, develops medicines focusing on oncology and immunology primarily in the United States and Europe. The company's pipeline products comprise GLPG3667 that is in phase 2 clinical trial in dermatomyositis and systemic lupus erythematosus; GLPG5101, a CD19 CAR-T product candidate manufactured at point-of-care, currently in Phase1/2 trial in relapsed/refractory non-hodgkin lymphoma; and GLPG5301, a BCMA CAR-T product candidate manufactured at point-of-care, curre...

Industry: Biotechnology
Sector: Healthcare
Phone: 32 1 534 29 00
Fax: 32 1 534 29 01
Address:
Generaal De Wittelaan L11 A3, Mechelen, Belgium
dogred111
dogred111 May. 14 at 4:10 PM
0 · Reply
OfficialStocktwitsUser
OfficialStocktwitsUser May. 12 at 7:04 PM
$GLPG RSI: 37.28, MACD: -0.5464 Vol: 0.54, MA20: 28.54, MA50: 30.10 🔴 SELL - Downtrend 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply
StocktwitsEarnings
StocktwitsEarnings May. 6 at 9:25 PM
$GLPG Q1 '26 Earnings Results & Recap • Reported GAAP EPS of $0.22 up 109.44% YoY • Reported revenue of $6.48M down -91.36% YoY • Galapagos expects its year-end 2026 cash and financial investments balance to be in the range of 1.98B to 2.05B, a reduction from prior guidance due to Ouro investment and lower interest income.
0 · Reply
Auphiliate
Auphiliate Mar. 30 at 10:43 PM
$AUPH Gilead Sciences owns 25% of $GLPG 🧐
0 · Reply
Auphiliate
Auphiliate Mar. 30 at 4:44 PM
$AUPH Does Tang still own 7.5% of $GLPG? 🤔
2 · Reply
Auphiliate
Auphiliate Mar. 30 at 3:45 PM
$GLPG=G (et) L (ost) PG !!! 😂
0 · Reply
Auphiliate
Auphiliate Mar. 30 at 3:38 PM
$AUPH Interesting reading over at stocktwits $GLPG! 😁
0 · Reply
PaidPiper
PaidPiper Mar. 27 at 1:35 AM
$GLPG Adaptimmune filed a 'change of address' wednesday evening. Right next door to Immunocore. Deal coming soon. This isn't spam, you won't hear from me again. Godspeed.
0 · Reply
PaidPiper
PaidPiper Mar. 26 at 8:07 PM
$GLPG smh... you guys could've had it all
0 · Reply
JFais
JFais Mar. 24 at 7:21 PM
$CGEM- nice red to green today as the market digests $GILD $GLPG Ouro $1.6B buyout & readthrough to T-cell engager space on the whole
0 · Reply
Latest News on GLPG
No data available.
dogred111
dogred111 May. 14 at 4:10 PM
0 · Reply
OfficialStocktwitsUser
OfficialStocktwitsUser May. 12 at 7:04 PM
$GLPG RSI: 37.28, MACD: -0.5464 Vol: 0.54, MA20: 28.54, MA50: 30.10 🔴 SELL - Downtrend 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply
StocktwitsEarnings
StocktwitsEarnings May. 6 at 9:25 PM
$GLPG Q1 '26 Earnings Results & Recap • Reported GAAP EPS of $0.22 up 109.44% YoY • Reported revenue of $6.48M down -91.36% YoY • Galapagos expects its year-end 2026 cash and financial investments balance to be in the range of 1.98B to 2.05B, a reduction from prior guidance due to Ouro investment and lower interest income.
0 · Reply
Auphiliate
Auphiliate Mar. 30 at 10:43 PM
$AUPH Gilead Sciences owns 25% of $GLPG 🧐
0 · Reply
Auphiliate
Auphiliate Mar. 30 at 4:44 PM
$AUPH Does Tang still own 7.5% of $GLPG? 🤔
2 · Reply
Auphiliate
Auphiliate Mar. 30 at 3:45 PM
$GLPG=G (et) L (ost) PG !!! 😂
0 · Reply
Auphiliate
Auphiliate Mar. 30 at 3:38 PM
$AUPH Interesting reading over at stocktwits $GLPG! 😁
0 · Reply
PaidPiper
PaidPiper Mar. 27 at 1:35 AM
$GLPG Adaptimmune filed a 'change of address' wednesday evening. Right next door to Immunocore. Deal coming soon. This isn't spam, you won't hear from me again. Godspeed.
0 · Reply
PaidPiper
PaidPiper Mar. 26 at 8:07 PM
$GLPG smh... you guys could've had it all
0 · Reply
JFais
JFais Mar. 24 at 7:21 PM
$CGEM- nice red to green today as the market digests $GILD $GLPG Ouro $1.6B buyout & readthrough to T-cell engager space on the whole
0 · Reply
JFais
JFais Mar. 24 at 7:19 PM
$CGEM nice red to green today as the market digests $GILD $GLPG Ouro $1.6B buyout & repercussions
0 · Reply
aletz
aletz Mar. 24 at 3:54 PM
$INAB $GILD acquired private biotech company Ouro Medicine, an early-stage TCE biotech company, for $2.1 billion. The acquisition involves a cost-sharing agreement with $GLPG. TCE assets have been highly sought after in the biotech deal landscape recently. For instance, $SNY committed another $1 billion yesterday for a deal with California-based Kali Therapeutics, another early-stage TCE biotech company. INAB has a strong chance of securing a deal if INB-619 demonstrates promising data later this year.
1 · Reply
briefingcom
briefingcom Mar. 24 at 12:39 PM
$GILD: Gilead Sciences to acquire Ouro Medicines in $2.2 bln autoimmune deal; Galapagos $GLPG eyes partnership with Gilead
0 · Reply
notreload_ai
notreload_ai Mar. 24 at 10:58 AM
$GILD to acquire Ouro Medicines for $1.675B upfront + $500M milestones, adding clinical-stage BCMAxCD3 therapy gamgertamig for severe autoimmune conditions. Partnership with $GLPG announced. https://notreload.xyz/gilead-acquires-ouro-medicines-in-autoimmune-push/
0 · Reply
dgbio
dgbio Mar. 24 at 4:31 AM
$GLPG At last, some activity. Ouro deal looks not bad.
0 · Reply
BillionerOfKing
BillionerOfKing Feb. 28 at 4:38 AM
$GLPG Current Stock Price: $33.70 Contracts to trade: $32.5 GLPG Apr 17 2026 Call Entry: $1.80 Exit: $2.28 ROI: 26% Hold ~26 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts
0 · Reply
StocktwitsEarnings
StocktwitsEarnings Feb. 23 at 10:25 PM
$GLPG Q4 '25 Earnings Results & Recap • Reported GAAP EPS of $2.44 up 542.11% YoY • Reported revenue of $900.77M up 1093.16% YoY • Galapagos expects to be cash flow neutral to positive by the end of 2026, anticipating 2.78B to 2.85B in cash and financial investments at year-end. Restructuring cash costs are projected between 125M and 175M for 2026.
0 · Reply
OfficialStocktwitsUser
OfficialStocktwitsUser Feb. 21 at 4:29 PM
$GLPG RSI: 48.97, MACD: 0.1751 Vol: 0.42, MA20: 34.07, MA50: 33.28 🔴 SELL - Downtrend 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply
BillionerOfKing
BillionerOfKing Feb. 5 at 2:25 PM
$GLPG Current Stock Price: $34.62 Contracts to trade: $35.0 GLPG Feb 20 2026 Call Entry: $1.35 Exit: $1.86 ROI: 37% Hold ~20 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts
0 · Reply
MandelbrotMarkets
MandelbrotMarkets Feb. 4 at 9:55 AM
$GLPG biotech, European R&D
0 · Reply
hegdaom
hegdaom Jan. 27 at 12:18 PM
0 · Reply